Observational studyRMD open2026

Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activity.

Alp Temiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.